+ 1 888 391 5441

China Contract Research Organization (CRO) Industry Report, 2019-2025

Table of Contents

1. Overview of Pharmaceutical Outsourcing
1.1 Definition
1.2 Classification
1.3 CRO

2. Evolution of Global CRO Industry
2.1 Development History
2.2 Development Background
2.2.1 Pharmaceutical Industry Size
2.2.2 Pharmaceutical Companies Development
2.2.3 Pharmaceutical R&D
2.3 Market Size
2.4 Competitive Landscape

3. CRO Industry in China
3.1 Development Environment
3.1.1 Regulation
3.1.2 Policy Environment
3.1.3 Industry Environment
3.2 Status Quo
3.3 Market Size
3.4 Competitive Landscape
3.5 Development Trend
3.5.1 Transnational Pharmaceutical Companies Shut Down and Have a Clearance Sale of Their Research Centers in China, which Favors Local Chinese Companies
3.5.2 New Drug Approvals Increase and R&D Expenses Grow, Setting the Stage for CRO Industry
3.5.3 The Amounting Pressure from R&D Costs Make Pharmaceutical Enterprises Rely More on CRO Companies for the Research and Development of New Drugs
3.5.4 Favorable Policies and Capital Promote the Development of Local Chinese Companies
3.5.5 Good Prospects Attract the Enterprises’ Access into CRO Industry
3.5.6 The Industry Heads toward Vertical Integration
3.5.7 M&A May Become the Main Way for CRO Companies to Expand
3.5.8 The Comprehensive Implementation of Consistency Assessment Brings Development Opportunities to the CRO Industry

4. Major Chinese Companies
4.1 Wuxi AppTec
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure
4.1.4 Gross Margin
4.1.5 Major Clients
4.1.6 R&D Investment
4.1.7 CRO Business
4.1.8 Development Strategy
4.2 Hangzhou Tigermed
4.2.1 Profile
4.2.2 Operation
4.2.3 Revenue Structure
4.2.4 Gross Margin
4.2.5 R&D Investment
4.2.6 Development Strategy
4.3 Guangzhou Boji Pharmaceutical
4.3.1 Profile
4.3.2 Operation
4.3.3 Revenue Structure
4.3.4 Gross Margin
4.3.5 R&D Investment
4.3.6 Development Strategy
4.4 Shanghai Meidicilon Inc.
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 Gross Margin
4.4.5 R&D Investment
4.4.6 Major Clients
4.4.7 Development Strategy
4.5 Porton Fine Chemicals
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure
4.5.4 Gross Margin
4.5.5 R&D Investment
4.5.6 Major Clients
4.5.7 Development Strategy
4.6 Joinn Laboratories
4.6.1 Profile
4.6.2 Operation
4.6.3 Revenue Structure
4.6.4 Gross Margin
4.6.5 R&D Investment
4.6.6 Major Clients
4.6.7 Development Strategy
4.7 Pharmaron
4.7.1 Profile
4.7.2 Operation
4.7.3 Revenue Structure
4.7.4 Gross Margin
4.7.5 R&D Investment
4.7.6 Major Clients
4.7.7 Development Strategy
4.8 Obio Technology (Shanghai)
4.8.1 Profile
4.8.2 Operation
4.8.3 Revenue Structure
4.8.4 Gross Margin
4.8.5 R&D Investment
4.8.6 Major Clients
4.8.7 Development Strategy
4.9 Nanjing Huawe Medicine Technology Group Co., Ltd.
4.9.1 Profile
4.9.2 Major Clients
4.9.3 Main Business
4.10 Shanghai ChemPartner
4.10.1 Profile
4.10.2 Main Business
4.10.3 Revenue Structure
4.10.4 Major Clients

5 Major Foreign Companies
5.1 LabCorp
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 CRO Business
5.1.5 Development in China
5.2 IQVIA
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Development Strategy
5.2.5 Development in China
5.3 Parexel
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Development in China
5.4 Charles River
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 Development in China
5.5 PPD
5.5.1 Profile
5.5.2 Development in China
5.5.3 BioDuro
5.5.4 Excel PharmaStudies
5.6 Syneos Health
5.6.1 Profile
5.6.2 Operation
5.6.3 Revenue Structure
5.6.4 CRO Business
5.6.5 Development in China
5.7 PRA
5.7.1 Profile
5.7.2 Operation
5.7.3 Development in China
5.8 ICON
5.8.1 Profile
5.8.2 Operation
5.8.3 Revenue Structure
5.8.4 Development in China

List of Charts

Classification of Pharmaceutical Outsourcing
R&D Process of New Drugs
Corresponding Relationship between New Drug R & D Process, New Drug R & D Discipline and CRO Services
New Drug R&D Cost Structure
Global Pharmaceutical Market Size, 2012-2018
Global Pharmaceutical Market Size, 2018-2025E
Global Pharmaceutical Market Size (by Type), 2012-2018
Global Pharmaceutical Market Size (by Type), 2012-2025E
Global Pharmaceutical Market Size (by Region), 2012-2018E
Global Pharmaceutical Market Size (by Region), 2018-2025E
TOP20 Pharmaceutical Companies by Revenue, 2017
New Drug Approvals of Global Pharmaceutical Companies (by Company Size), 2013-2022E
Global Pharmaceutical R & D Investment (by Company Size), 2013-2018
Global Pharmaceutical R & D Investment (by Company Size), 2018-2025E
Global Pharmaceutical R & D Investment (by Medicine Type), 2013-2018
Global Pharmaceutical R & D Investment (by Medicine Type), 2018-2025E
Average Costs of New Drugs from R&D to Approved Launch
Cumulative Success Rate of New Drug R&D from Phase I to III
Number of Drugs in R&D (by Phase), 2017 VS 2016
Scale and YoY Growth of Global CRO Industry, 2011-2018
Scale and YoY Growth of Global CRO Industry, 2018-2025E
Comparison between Global Major CRO Companies
Market Share of Major Global CRO Companies, 2018
M&A Cases of Global Major CRO Companies
Comparison of Major Global CRO Companies by Revenue, 2014-2018
Policies on China’s CRO Industry, 2010-2018
China Pharmaceutical Market Size and % in Global Total, 2012-2018
China Pharmaceutical Market Size and % in Global Total, 2018-2025E
China Pharmaceutical Market Size (by Type), 2012-2018
China Pharmaceutical Market Size (by Type), 2018-2025E
China Pharmaceutical R & D Investment and % in Global Total, 2013-2018
China Pharmaceutical R & D Investment and % in Global Total, 2018-2025E
Development Course of CRO Industry in China
Comparison of Pharmaceutical R&D Costs in China and Developed Countries
Cases of Multinational Pharmaceutical Enterprises’ R&D Centers in China, 2001-2018
Scale and YoY Growth of China’s CRO Industry, 2011-2018
Scale and YoY Growth of China’s CRO Industry, 2018-2025E
Layout of Major Global CRO Companies in Asia
Comparison of Major Chinese CRO Companies
Market Share of Major Chinese CRO Companies, 2017
Market Share of Major Chinese CRO Companies, 2018
Comparison of Major Chinese CRO Companies by Revenue, 2014-2018
Comparison of Major Chinese CRO Companies by Net Income, 2014-2018
Listing of Local Chinese CRO Companies
Layout of Chinese Companies in CRO, 2015-2017
M & A Cases of Chinese CRO Companies, 2016-2018
China's Policies on Consistency Assessment, 2012-2018
Major Business of Wuxi AppTec
Serivce Provided by Wuxi AppTec to Pharmaceutical Companies in New Medicine R&D Stage
Revenue and Net Income of Wuxi AppTec, 2014-2018
Revenue of Wuxi AppTec by Product, 2015-2018
Revenue of Wuxi AppTec by Region, 2014-2017
Revenue Structure of Wuxi AppTec by Region, 2014-2017
Gross Margin of Wuxi AppTec, 2015-2018
Gross Margin of Wuxi AppTec by Product, 2015-2018
Revenue from Top Ten Clients of Wuxi AppTec, 2015-2017
R&D Investment and % of Total Revenue of Wuxi AppTec, 2014-2018
IPO Raised Investment Projects of Wuxi AppTec
Revenue from CRO Business (by Sector) of Wuxi AppTec, 2014-2018
Gross Margin of CRO Business (by Sector) of Wuxi AppTec, 2014-2018
Revenue and Net Income of Tigermed, 2013-2018
Revenue of Tigermed by Business, 2014-2018
Revenue Structure of Tigermed by Business, 2014-2018
Revenue of Tigermed by Region, 2014-2018
Revenue Structure of Tigermed by Region, 2014-2018
Gross Margin of Tigermed by Business, 2014-2018
R&D Investment of Tigermed and % of Total Revenue, 2013-2018
Expansion Course of Tigermed, 2004-2017
Main Business of Boji Medical Biotechnological
Revenue and Net Income of Boji Medical Biotechnological, 2014-2018
Revenue of Boji Medical Biotechnological by Business, 2014-2018
Revenue Structure of Boji Medical Biotechnological, 2014-2018
Gross Margin of Boji Medical Biotechnological by Product, 2014-2018
R&D Investment of Boji Medical Biotechnological and % of Total Revenue, 2014-2018
IPO Project Progress of Boji Medical Biotechnological, as of H1 2018
Development Course of Meidicilon
Revenue and Net Income of of Meidicilon, 2014-2016
Revenue of Meidicilon by Business, 2014-2016
Revenue Structure of Meidicilon by Business, 2014-2016
Revenue of Meidicilon by Region, 2014-2016
Gross Margin of Meidicilon by Business, 2014-2016
R&D Investment of Meidicilon and % of Total Revenue, 2014-2016
IPO Fund-raised Projects of Meidicilon, 2017
Top Five Clients of Meidicilon and % in Total Revenue, 2014-2016
Revenue and Net Income of Porton, 2014-2018
Revenue of Porton by Business, 2014-2017
Revenue Structure of Porton by Business, 2014-2017
Revenue of Porton by Region, 2014-2018
Revenue Structure of Porton by Region, 2014-2018
Gross Margin of Porton by Business, 2014-2017
R&D Investment of Porton and % of Total Revenue, 2014-2017
Subscription of Porton in Establishment of the Industrial Fund, 2019
Revenue from Top 5 Clients of Porton and % in Total Revenue, 2015-2017
Revenue and Net Income of JOINN Laboratories, 2014-2018
Revenue of JOINN Laboratories (by Business), 2014-2018
Revenue Structure of JOINN Laboratories (by Business), 2014-2018
Gross Margin of JOINN Laboratories, 2014-2018
Business Advantages of JOINN Laboratories
R & D Expenditure of JOINN Laboratories and % of Total Revenue, 2014-2018
Investment Projects of JOINN Laboratories by Raising Funds via IPO, 2017
JOINN Laboratories’ Revenue from Top 5 Clients and % of Total Revenue, 2014-2017
Pharmaron’s Revenue and Net Income, 2014-2018
Pharmaron’s Revenue (by Business), 2014-2018
Pharmaron’s Revenue (by Region), 2015-2018
Pharmaron’s Gross Margin, 2015-2018
Pharmaron’s Gross Margin (by Business), 2015-2018
Composition of Pharmaron’s R & D Division
Pharmaron’s Staff Structure by Division, as of June 30, 2018
Pharmaron’s M&A Cases, 2016-2017
Pharmaron’s Revenue from Top 5 Clients and % of Total Revenue, 2014-2018
Revenue and Net Income of Obio Technology (Shanghai), 2014-2018
Revenue of Obio Technology (Shanghai) by Business, 2014-2018
Revenue Structure of Obio Technology (Shanghai) by Business, 2014-2018
Gross Margin of Obio Technology (Shanghai), 2014-2018
R&D Investment of Obio Technology (Shanghai) and % of Total Revenue, 2014-2018
Revenue from Top 5 Clients of Obio Technology (Shanghai) and % in Total Revenue, 2014-2017
Major Clients of Huawe Medicine
Progress of Innovation Projects of Huawe Medicine under R&D
Development Course of Shanghai ChemPartner
Equity Structure of Shanghai ChemPartner’s Subsidiaries
Main Content of Shanghai ChemPartner’s CRO Business
Main Content of Shanghai ChemPartner’s CMO Business
Revenue of Shanghai ChemPartner (by Business), 2015-2018
Revenue Structure of Shanghai ChemPartner (by Business), 2015-2018
Shanghai ChemPartner’s Revenue from Major Customers and % of Total Revenue, 2015-2017
LabCorp’s Revenue and Net Income, 2013-2018
LabCorp’s Revenue (by Division), 2013-2018
LabCorp’s Revenue Structure (by Division), 2013-2018
LabCorp’s CRO Revenue and % of Total Revenue, 2013-2018
Revenue and Net Income of IQVIA, 2014-2018
Operating Revenue of IQVIA by Region and by Business, 2016-2018
Operating Revenue Structure of IQVIA by Region and by Business, 2016-2018
Business Scope of Parexel
Revenue and Net Income of Parexel, FY2014-FY2017
Operating Revenue of Parexel (by Division), FY2014-FY2017
Operating Revenue Structure of Parexel (by Division), FY2014-FY2017
Branches of Parexel in China, as of 2017H1
Revenue and Net Income of Charles River, 2014-2018
Revenue of Charles River (by Division), 2014-2018
Revenue Structure of Charles River (by Division), 2014-2018
Revenue and Net Income of Syneos, 2013-2018
Revenue of Syneos by Business, 2015-2018
Revenue Structure of Syneos by Business, 2015-2018
CRO Revenue and Growth of Syneos, 2015-2018
Revenue and Net Income of PRA, 2014-2018
M&A Course of ICON, 2000-2019
Revenue and Net Income of ICON, 2014-2018
Revenue of ICON by Region, 2016-2018

Why http://www.chinamarketresearchreports.com
China Contract Research Organization (CRO) Industry Report, 2019-2025
Published By :Research In China
Price

Buy Any Report Avail 15% Discount. Coupon Code: AUG15

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy